英語論文

2021年

  1. Yokota K, Kurihara I, Matsusaka Y, Emoto K, Hishida T, Oshida T, Kobayashi S, Murai-Takeda A, Miyashita K, Matsuda K, Nakagomi T, Matsuda K, Itoh H
    Mediastinal Cystic Parathyroid Adenoma Diagnosed by Somatostatin Receptor Scintigraphy
    Intern Med 60(10):1555-1560, 2021
  2. Yokota K, Shibata H, Kurihara I, Kobayashi S, Muraii-Takeda A, Itoh H
    CASZ1b is a novel transcriptional corepressor of mineralocorticoid receptor
    Hypertens Res 44(4):407-416, 2021
  3. Okamoto K, Ohno Y, Sone M, Inagaki N, Ichijo T, Yoneda T, Tsuiki M, Wada N, Oki K, Tamura K, Kobayashi H, Izawa S, Tanabe A, Naruse M
    Should Adrenal Venous Sampling Be Performed in PA Patients Without Apparent Adrenal Tumors?
    Front Endocrinol 12:645395, 2021
  4. Haze T, Hirawa N, Yano Y, Tamura K, Kurihara I, Kobayashi H, Tsuiki M, Ichijo T, Wada N, Katabami T, Yamamoto K, Oki K, Inagaki N, Okamura S, Kai T, Izawa S, Yamada M, Chiba Y, Tanabe A, Naruse M
    Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism
    Atherosclerosis 324:84-90, 2021
  5. Okamoto K, Ohno Y, Sone M, Inagaki N, Ichijo T, Yoneda T, Tsuiki M, Wada N, Oki K, Tamura K, Kobayashi H, Izawa S, Tanabe A, Naruse M
    Should Adrenal Venous Sampling Be Performed in PA Patients Without Apparent Adrenal Tumors?
    Front Endocrinol 12:645395, 2021
  6. Nishimoto K, Umakoshi H, Seki T, Yasuda M, Araki R, Otsuki M, Katabami T, Shibata H, Ogawa Y, Wada N, Sone M, Okamura S, Izawa S, Miyauchi S, Yoshimoto T, Tsuiki M, Naruse M, JRAS Study Group
    Diverse pathological lesions of primary aldosteronism and their clinical significance
    Hypertens Res 44(5):498-507, 2021
  7. Nakamaru R, Yamamoto K, Akasaka H, Rakugi H, Kurihara I, Yoneda T, Ichijo T, Katabami T, Tsuiki M, Wada N, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Fujita M, Watanabe M, Kamemura K, Okamura S, Tanabe A, Naruse M, JPAS/JRAS Study Group
    Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism
    Sci Rep 11(1):6925, 2021
  8. Nakamaru R, Yamamoto K, Akasaka H, Rakugi H, Kurihara I, Yoneda T, Ichijo T, Katabami T, Tsuiki M, Wada N, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Fujita M, Oki K, Kamemura K, Tanabe A, Naruse M, JPAS/JRAS study group
    Sex Differences in Renal Outcomes After Medical Treatment for Bilateral Primary Aldosteronism
    Hypertension 77(2):537-545, 2021
  9. Yasuda T, Murakami T, Yasoda A, Sone M, Norio H, Ogura M, Inagaki N
    Clinical Practice Changes After Post-Market Safety Reports on Desmopressin Orally Disintegrating Tablet in Japan: A Single-Center Retrospective Study
    J Clin Med Res 13(2):92-100, 2021
  10. Yamamoto Y, Nagai Y, Kawanabe S, Hishida Y, Hiraki K, Sone M, Tanaka Y
    Effects of resistance training using elastic bands on muscle strength with or without a leucine supplement for 48 weeks in elderly patients with type 2 diabetes
    Endocr J 68(3):291-298, 2021
  11. Takao K, Iizuka K, Liu Y, Sakurai T, Kubota S, Kubota-Okamoto S, Imaizumi T, Takahashi Y, Rakhat Y, Komori S, Hirose T, Nonomura K, Kato T, Mizuno M, Suwa T, Horikawa Y, Sone M, Yabe D
    Effects of ChREBP deficiency on adrenal lipogenesis and steroidogenesis
    J Endocrinol 248(3):317-324, 2021
  12. Ohno Y, Naruse M, Beuschlein F, Schreiner F, Parasiliti-Caprino M, Deinum J, Drake WM, Fallo F, Fuss CT, Grytaas MA, Ichijo T, Inagaki N, Kakutani M, Kastelan D, Kraljevic I, Katabami T, Kocjan T, Monticone S, Mulatero P, O’Toole S, Kobayashi H, Sone M, Tsuiki M, Wada N, Williams TA, Reincke M, Tanabe A
    Adrenal venous sampling guided adrenalectomy rates in primary aldosteronism: results of an international cohort (AVSTAT)
    J Clin Endocrinol Metab 106(3):e1400-e1407, 2021
  13. Hiruma M, Sasano Y, Watanabe N, Yoshihara A, Ishii S, Yaguchi Y, J Yoshimura N, Sugino K, Ito K
    Propylthiouracil-induced otitis media with antineutrophil cytoplasmic antibody-associated vasculitis: a case report and review of the literature
    Endocr J 68(2):145-151, 2021

2020年

  1. Kimura N, Shiga K, Kaneko K, Sugisawa C, Katabami T, Naruse M
    The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma
    Endocr Pathol 31(2):95-100, 2020
  2. Nakayama T, Nagai Y, Yasunaka Y, Uraguchi T, Wada Y, Sone M, Tanaka Y
    Effect of Eating Glutinous Brown Rice Twice a Day for 6 Weeks on Serum 1,5-Anhydroglucitol in Japanese Subjects without Diabetes
    J Nutr Metab 2020:8847781
  3. Imai T, Shibata S, Shinohara K, Sakurai K, Horiuchi M, Sakai K, Asai S, Hasegawa Y
    IgG4-related hypophysitis diagnosed by retroperitoneal mass biopsy in a patient presenting with abducens nerve palsy
    Medicine 99(40):e22484, 2020
  4. Katabami T, Tsukiyama H, Tanabe M, Matsuba R, Murakami M, Nishine A, Shimizu S, Sakai K, Tanaka Y & Yanase T
    Development of a simple prediction model for adrenal crisis diagnosis
    Sci Rep 10(1):13546, 2020
  5. Kobayashi Y, Haze T, Yano Y, Tamura K, Kurihara I, Ichijo T, Yoneda T, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yamada T, Okamoto R, Fujita M, Kamemura K, Yamamoto K, Izawa S, Tanabe A and Naruse M and JPAS/JRAS Study Group
    Associations Between Changes in Plasma Renin Activity and Aldosterone Concentrations and Changes in Kidney Function After Treatment for Primary Aldosteronism
    Kidney Int Rep 5(8):1291-1297, 2020
  6. Yamasaki Y, Ooka S, Tsuchida T, Nakamura Y, Hagiwara Y, Naitou Y, Ishibashi Y, Ikeda H, Sakurada T, Handa H, Nishine H, Takita M, Morikawa D, Yoshida H, Fujii S, Morisawa K, Takemura H, Fujitani S, Kunishima H
    The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide
    Virus Res 290:198089, 2020
  7. Ohno Y, Sone M, Inagaki N, Kawashima A, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Ichijo T, Katabami T, Wada N, Sakamoto R, Ogawa Y, Yoshimoto T, Yamada T, Kawashima J, Matsuda Y, Kobayashi H, Kamemura K, Yamamoto K, Otsuki M, Okamura S, Izawa S, Okamoto R, Tamura K, Tanabe A, Naruse M; JPAS/JRAS Study Group
    Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism
    Hypertension 75(6):1475-1482, 2020
  8. Naruse M, Yamamoto K, Katabami T, Nakamaru R, Sone M, Kobayashi H, Tanabe A
    Age, Gender, and Body Mass Index as Determinants of Surgical Outcome in Primary Aldosteronism
    Horm Metab Res 52(6):454-458, 2020
  9. Tsujimoto H, Kasahara T, Sueta SI, Araoka T, Sakamoto S, Okada C, Mae SI, Nakajima T, Okamoto N, Taura D, Nasu M, Shimizu T, Ryosaka M, Li Z, Sone M, Ikeya M, Watanabe A, Osafune K.
    A Modular Differentiation System Maps Multiple Human Kidney Lineages from Pluripotent Stem Cells
    Cell Rep 31(1):107476, 2020
  10. Saiki A, Otsuki M, Tamada D, Kitamura T, Shimomura I, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Yanase T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Okamoto R, Takahashi K, Kobayashi H, Tamura K, Kamemura K, Yamamoto K, Izawa S, Kakutani M, Yamada M, Tanabe A, Naruse M
    Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary Aldosteronism
    J Clin Endocrinol Metab 105(7):dgaa177, 2020
  11. Taura D, Nakao K, Nakagawa Y, Kinoshita H, Sone M, Nakao K
    C-type natriuretic peptide (CNP)/guanylate cyclase B (GC-B) system and endothelin-1(ET-1)/ET receptor A and B system in human vasculature
    Can J Physiol Pharmacol 98(9):611-617, 2020
  12. Nakamaru R, Yamamoto K, Rakugi H, Akasaka H, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Yoshimoto T, Okamoto R, Fujita M, Kobayashi H, Tamura K, Kamemura K, Okamura S, Kakutani M, Tanabe A, Naruse M; JPAS/JRAS Study Group
    Obesity predicts persistence of resistant hypertension after surgery in patients with primary aldosteronism
    Clin Endocrinol (Oxf) 93(3):229-237, 2020
  13. Hatoko T, Murakami T, Sone M, Yabe D, Masui T, Nakamoto Y, Furuta A, Uza N, Kodama Y, Harada N, Ogura M, Yasoda A, Inagaki N
    Low-dose Selective Arterial Calcium Stimulation Test for Localizing Insulinoma: A Single-center Experience of Five Consecutive Cases
    Intern Med 59(19):2397-2403, 2020
  14. Saiki A, Otsuki M, Mukai K, Hayashi R, Shimomura I, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Okamoto R, Takahashi K, Kobayashi H, Tamura K, Kamemura K, Yamamoto K, Izawa S, Kakutani M, Yamada M, Tanabe A, Naruse M, JPAS/JRAS Study Group
    Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism
    J Endocr Soc 4(4):1-12, 2020
  15. Kobayashi H, Nakamura Y, Abe M, Kurihara I, Itoh H, Ichijo , Takeda Y, Yoneda T, Katabami T, Tsuiki M, Wada N, Ogawa Y, Sakamoto R, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Yamada T, Okamoto R, Matsuda Y, Fujita M, Watanabe M, Tamura K, Tanabe A, Naruse M, JPAS/JRAS Study Group
    Effect of cosyntropin during adrenal venous sampling on subtype of primary aldosteronism: analysis of surgical outcome
    Eur J Endocrinol 182(3):265-273, 2020
  16. Ishii S, Nagai Y, Kato H, Fukuda H, Tanaka Y
    Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Muscle Mass and the Muscle/Fat Ratio in Patients With Type 2 Diabetes
    J Clin Med Res 12(2):122-126, 2020

2019年

  1. Nakagawa T, Nagai Y, Yamamoto Y, Miyachi A, Hamajima H, Mieno E, Takahashi M, Inoue E, Tanaka Y
    Effects of anagliptin on plasma glucagon levels and gastric emptying in patients with type 2 diabetes: an exploratory randomized controlled trial versus metformin
    Diabetes Res Clin Pract 158:107892, 2019
  2. Morisaki M, Kurihara I, Itoh H, Naruse M, Takeda Y, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Sone M, Tsuiki M, Shibata H, Kawashima J, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Suzuki T, JPAS Study Group
    Predictors of Clinical Success After Surgery for Primary Aldosteronism in the Japanese Nationwide Cohort
    J Endocr Soc 3:2012-2022, 2019
  3. Kyo C, Usui T, Kosugi R, Torii M, Yonemoto T, Ogawa T, Kotani M, Tamura N, Yamamoto Y, Katabami T, Kurihara I, Saito K, Kanamoto N, Fukuoka H, Wada N, Murabe H, Inoue T
    ARMC5 Alterations in Primary Macronodular Adrenal Hyperplasia (PMAH) and the Clinical State of Variant Carriers
    J Endocr Soc 3:1837-1846, 2019
  4. Takekoshi K, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura , Tanaka T,Matsuda T, Imai T, Yamada M, Asada S, Kawata N, Naruse M
    Correlation between urinary fractionated metanephrines in 24-hour and spot urine samples for evaluating the therapeutic effect of metyrosine: a subanalysis of a multicenter, open-label phase I/II study
    Endocr J 66:1063-1072, 2019
  5. Fujii Y, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Fujita M, Suzuki T, Umakoshi H, Ogasawara T, Tsuiki M, Naruse M, JPAS Study Group
    Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan
    J Hum Hypertens 34:34-42, 2020
  6. Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, Umakoshi , Ichijo , Katabami T, Wada N, Ogawa Y, Kawashima J, Fujita M, Miyauchi S, Okamura S, Fukuoka T, Yanase T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Kai T, Suzuki T, Naruse M
    Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism
    Eur J Endocrinol 181:339-350, 2019
  7. Ohno Y, Sone M, Inagaki N, Takeda Y, Kurihara I, Tsuiki M, Ichijo T, Wada N, Katabami T, Ogawa Y, Okamura S, Fukuoka T, Kai T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Chiba Y, Naruse M, JPAS/JRAS Study Group
    Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism
    J Clin Endocrinol Metab 104:4382-4389, 2019
  8. Kobayashi H, Abe M, Nakamura Y, Takahashi K, Fujita M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Wada N, Ichijo T, Katabami T, Ogawa Y, Kawashima J, Yoshimoto T, Sone M, Inagaki N, Watanabe M, Kamemura K, Matsuda Y, Izawa S, Tanabe M, Tanabe A, Suzuki T, Naruse M, JPAS/JRAS Study Group
    Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function
    Hypertension 74:630-638, 2019
  9. Akasaka H, Yamamoto K, Rakugi H, Nagasawa M, Nakamaru R, Ichijo T, Takeda Y, Kurihara I, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Kamemura K, Yoshimoto T, Matsuda Y, Fujita M, Kobayashi H, Watanabe M, Tamura K, Okamura S, Miyauchi S, Izawa S, Chiba Y, Tanabe A, Naruse M, Japan Primary Aldosteronism Study Group
    Sex Difference in the Association Between Subtype Distribution and Age at Diagnosis in Patients With Primary Aldosteronism
    Hypertension 74:368-374, 2019
  10. Wada N, Shibayama Y, Yoneda T, Katabami T, Kurihara I, Tsuiki M, Ichijo T, Ogawa Y, Kawashima J, Sone M, Yoshimoto T, Matsuda Y, Fujita M, Kobayashi H, Tamura K, Kamemura K, Otsuki M, Okamura S, Naruse M, JPAS/JRAS Study Group
    Lateralizing Asymmetry of Adrenal Imaging and Adrenal Vein Sampling in Patients With Primary Aldosteronism
    J Endocr Soc 3:1393-1402, 2019
  11. Nagai Y, Fukuda H, Kawanabe S, Nakagawa T, Ohta A, Tanaka Y
    Differing Effect of the Sodium-Glucose Contransporter 2 Inhibitor Ipragliflozin on the Decrease of Fat Mass vs. Learn Mass in Patients With or Without Metformin Therapy
    J Clin Med Res 11:297-300, 2019
  12. Nakamura Y, Nagai Y, Toshio K, Furukawa K, Oikawa Y, Shimada A, Tanaka Y
    Characteristics of Gut Microbiota in Patients With Diabetes Determined by Data Mining Analysis of Terminal Restriction Fragment Length Polymorphisms
    J Clin Med Res 11:401-406, 2019
  13. Takeda Y, Umakoshi H, Takeda Y, Yoneda T, Kurihara I, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Suzuki T, Naruse M; JPAS Study Group.
    Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism
    J Hypertens 37:1077-1082, 2019
  14. Ishii S, Nagai Y, Sada Y, Fukuda H, Nakamura Y, Matsuba R, Nakagawa T, Kato H, Tanaka Y
    Liraglutide Reduces Visceral and Intrahepatic Fat Without Significant Loss of Muscle Mass in Obese Patients With Type 2 Diabetes: A Prospective Case Series
    J Clin Med Res 11:219-224, 2019
  15. Kawanabe S, Nagai Y, Nakamura Y, Nishine A, Nakagawa T, Tanaka Y
    Association of the muscle/fat mass ratio with insulin resistance in gestational diabetes mellitusEndocr J 66:75-80, 2019
  16. Katabami T, Fukuda H, Tsukiyama H, Tanaka Y, Takeda Y, Kurihara I, Ito H, Tsuiki M, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Yanase T,Suzuki T, and Naruse M, JPAS/JRAS Study Group
    Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism
    J Hypertens 37:1513-1520, 2019
  17. Akehi Y, Yanase T, Motonaga R, Umakoshi H, Tsuiki M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T,and Naruse M, Japan Primary Aldosteronism Study Group
    High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan
    Diabetes Care 42:938-945, 2019
  18. Nagasawa M, Yamamoto K, Rakugi H, Takeda M, Akasaka H, Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Ichijo T, Katabami T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M,Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Ogo A, Okamura S, Miyauchi S, Yanase T, Suzuki T, Kawamura T, and Naruse M, JPAS Study Group
    Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling
    J Hypertens 37:1493-1499, 2019
  19. Takai M, Ishikawa M, Maeda H, Kanamori A, Kubota A, Amemiya H, Iizuka T, Iemitsu K, Iwasaki T, Uehara G, Umezawa S, Obana M, Kaneshige H, Kaneshiro M, Kawata T, Sasai N, Saito T, Takuma T, Takeda H, Tanaka K, Nakajima S, Hoshino K, Honda S, Machimura H, Matoba K, Minagawa F, Minami N, Miyairi Y, Mokubo A, Motomiya T, Waseda M, Miyakawa M, Terauchi Y, Tanaka Y, Matsuba I
    Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study
    J Clin Med Res 11:311-320, 2019

2018年

  1. Kobayashi H, Abe M, Soma M, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Shibata H, Kamemura K, Yanase T, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Nanba K, Tanabe A, Suzuki T, Naruse M; JPAS Study Group.
    Development and validation of subtype prediction scores for the workup of primary aldosteronism.
    J Hypertens 36:2269-2276, 2018
  2. Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Yoshimoto T, Kawashima J, Watanabe M, Matsuda Y, Kobayashi H, Shibata H,Miyauchi S, Kamemura K, Fukuoka T, Yamamoto K, Otsuki M, Suzuki T, Naruse M; JPAS Study Group.
    Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism
    J Clin Endocrinol Metab 103:4456-4464, 2018
  3. Takeda M, Yamamoto K, Akasaka H, Rakugi H, Naruse M, Takeda Y, Kurihara I, Itoh H, Umakoshi H,Tsuiki M, Ichijo T, Katabami T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Ogo A, Okamura S, Miyauchi S, Yanase T, Suzuki T, Kawamura T; JPAS Study Group.
    Clinical Characteristics and Postoperative Outcomes of Primary Aldosteronism in the Elderly
    J Clin Endocrinol Metab 103:3620-3629, 2018
  4. Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, Takeda Y, Takashi Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yanase T, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, Naruse M.
    Correlation Between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism
    J Endocr Soc 2:893-902, 2018
  5. Nagai Y, Nishine A, Hashimoto E, Nakayama T, Sasaki Y, Murakami M, Ishii S, Kato H, Tanaka Y
    Efficacy and safety of switching from basal insulin to once-daily insulin degludec/insulin aspart in Japanese patients with inadequately controlled type 2 diabetese: A 4-week, randomized, open-label, treat-to-target study
    J Diabetes Investig 9:567-572, 2018
  6. Murakami M, Nagai Y, Tenjin A, Tanaka Y
    Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study
    Endocr J 65:639-643, 2018
  7. Shibayama Y, Wada N, Naruse M, Kurihara I, Ito H, Yoneda T, Takeda Y, Umakoshi H, Tsuiki M, Ichijo T, Fukuda H, Katabami T, Yoshimoto T, Ogawa Y, Kawashima J, Ohno Y, Sone M, Fujita M, Takahashi K, Shibata H, Kamemura K, Fujii Y, Yamamoto K, Suzuki T
    The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for Primary Aldosteronism
    J Endocr Soc 2:398-407, 2018
  8. Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, Tanaka T, Kawate H, Tanabe M, Doi M, Akehi Y,Ichijo T
    New diagnostic criteria of adrenal subclinical Cushing’s syndrome: opinion from the Japan Endocrine Society
    Endocr J 65:383-393, 2018
  9. Umakoshi H, Ogasawara T, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y,obayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Okamura S,Miyauchi S, Suzuki T, Tsuiki M, Naruse M; JPAS Study Group
    Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism
    Clin Endocrinol (Oxf). 88:645-651, 2018
  10. Matsuba R, Matsuba I, Shimokawa M, Nagai Y, Tanaka Y
    Tofogliflozin decreases body fat mass and improves peripheral insulin resistance
    Diabetes Obes Metab 20:1311-1315, 2018
  11. Matsuba I, Matsuba R, Ishibashi S, Yamashita S, Arai H, Yokote K, Suganami H, Araki E
    Effects of a novel selective peroxisome proliferator-activated receptor α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance
    J Diabetes Investig 9:1323-1332, 2018
  12. Ikuno M, Yamada T, Shinjo Y, Morimoto T, Kumano R, Yagihashi K, Katabami T, Nakajima Y
    Selective venous sampling supports localization of adenoma in primary hyperparathyroidism
    Acta Radiol Open 7:1-9, 2018
  13. Naruse M, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura M, Tanaka T,Matsuda T, Imai T, Yamada M, Harada T, Kawata N, Takekoshi K
    Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan
    Endocr J 65:359-371, 2018
  14. Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Yanase T, Suzuki T, Naruse M, JPAS Study Group
    Significance of Computed Tomograpy and Serum Potassium in Predicting Subtype Diagnosis of Primary Aldosteronism
    J Clin Endocrinol Metab 103:900-908, 2018
  15. Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Ichijo T, Katabami T, Tanaka Y, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yoneda T, Hashimoto S, Yanase T, Suzuki T, Kawamura T, Tabara Y, Naruse M; Nagahama Study; JPAS Study Group.
    Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan
    Hypertension 71:530-537, 2018

2017年

  1. Sasaki Y, Katabami T, Asai S, Fukuda H, Tanaka Y
    In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing’s syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry
    Endocr J 64:833-842, 2017
  2. Ohta A, Kato H, Ishii S, Sasaki Y, Nakamura Y, Nakagawa T, Nagai Y, Tanaka Y
    Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes
    Expert Opin Pharmacother 18:1433-1438, 2017
  3. Iemitsu K, Kawata T, Iizuka T, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K, Asakura T, Kubota A, Aoyanagi S, Hoshino K, Ishikawa M, Matsuzawa Y, Obana M, Sasai N, Kaneshige H, Minagawa F, Saito T, Shinoda K, Miyakawa M, Tanaka Y, Terauchi Y, Matsuba I
    Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study
    J Clin Med Res 9:793-801, 2017
  4. Yamada T, Ikuno M, Shinjo Y, Hiroishi A, Matsushita S, Morimoto T, Kumano R, Yagihashi K, Katabami T
    Selective venous sampling for primary hyperparathyroidism: how to perform an examination and interpret the results with reference to thyroid vein anatomy
    Jpn J Radiol 35:409-416, 2017
  5. Kawata T, Iizuka T, Iemitsu K, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K, Asakura T, Kubota A, Aoyanagi S, Hoshino K, Ishikawa M, Matsuzawa Y, Obana M, Sasai N, Kaneshige H, Minagawa F, Saito T, Shinoda K, Miyakawa M, Tanaka Y, Terauchi Y, Matsuba I
    Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus
    J Clin Med Res 9:586-595, 2017
  6. Ohta A, Kato H, Ishii S, Nagai Y, Tanaka Y
    Effect of Ezetimibe Monotherapy on Low-Density Lipoprotein Cholesterol and on Markers of Cholesterol Synthesis and Absorption in Japanese Patients With Hypercholesterolemia
    J Clin Med Res 9:476-481, 2017
  7. Nakayama T, Nagai Y, Uehara Y, Nakamura Y, Ishii S, Kato H, Tanaka Y
    Eating glutinous brown rice twice a day for 8 weeks improves glycemic control in Japanese patients with diabetes mellitusNutr Diabetes 7:e273, 2017
  8. Terashima Y, Nagai Y, Kato H, Ohta A, Tanaka Y
    Eating glutinous brown rice for one day improves glycemic control in Japanese patients with type 2 diabetes assessed by continuous glucose monitoring
    Asia Pac J Clin Nutr 26:421-426, 2017
  9. Asai S, Katabami T, Tsuiki M, Tanaka Y, Naruse M
    Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas
    Horm Cancer 8:108-118, 2017
  10. Nagai Y, Ohta A, Sada Y, Kato H, Tanaka Y
    Effect of 24-week treatment with ipragliflozin on proinsulin/C-peptide ratio in Japanese patients with type 2 diabetes
    Expert Opin Pharmacother 18:13-17, 2017

 

2016年

  1. Yanase T, Tajima T, Katabami T, Iwasaki Y, Tanahashi Y, Sugawara A, Hasegawa T, Mune T, Oki Y, Nakagawa Y, Miyamura N, Shimizu C, Otsuki M, Nomura M, Akehi Y, Tanabe M, Kasayama S
    Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a japan Endocrine Society clinical practice guideline[Opinion]
    Endocr J 63:765-784, 2016
  2. Uzu T, Araki S, Kashiwagi A, Haneda M, Koya D, Yokoyama H, Kida Y, Ikebuchi M, Nakamura T,Nishimura M, Takahara N, Obata T, Omichi N, Sakamoto K, Shingu R, Taki H, Nagai Y, Tokuda H, Kitada M, Misawa M, Nishiyama A, Kobori H, Maegawa H, The Shiga Committee for Preventing Diabetic Nephropathy
    Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial
    PLOS ONE 11: e0164936, 2016
  3. Nemoto K, Ugi S, Ogaku S, Nakaizumi N, Kato T, Fuse K, Sekine O, Morino K, Tanaka T, Maegawa H
    A case of local delayed-type allergy to zinc-containing insulin as a cause of diabetic ketoacidosis in a patient with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion
    Diabetol Int 7: 447-450, 2016
  4. Katabami T, Ishii S, Obi R, Asai S, Tanaka Y
    Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas
    Endocr J 63:1123-1132, 2016
  5. Nagai Y, Murakami M, Igarashi K, Nakamura Y, Tsukiyama H, Matsubara F, Nishine A, Ohshige T, Ishii S, Kato H, Tanaka Y
    Efficacy and safety of thrice-weekly insulin degludec in elderly patients with type 2 diabetes assessed by continuous glucose monitoring
    Endocr J 63:1099-1106, 2016
  6. Matsubara F, Nagai Y, Tsukiyama H, Shimizu H, Yamanouchi E, Iwamoto T, Sada Y, Kato H, Ohta A,Tanaka Y
    Proposed cut-off value of the intrahepatic lipid content for metabolically normal persons assessed by proton magnetic resonance spectroscopy in a Japanese population
    Diabetes Res Clin Pract 119: 75-82, 2016
  7. Tsukiyama H, Nagai Y, Matsubara F, Shimizu H, Iwamoto T, Yamanouchi E, Sada Y, Kato H, Ohta A,Tanaka Y
    Proposed cut-off values of the waist circumference for metabolic syndrome based on visceral fat volume in a Japanese population
    J Diabetes Investig 7: 587-593, 2016
  8. Iemitsu K, Iizuka T, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H, Kawata T, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K, Asakura T, Kubota A, Aoyagi S, Hoshino K, Ishikawa M, Obana M, Sasai N, Kaneshige H, Miyakawa M, Tanaka Y, Terauchi Y, Matsuba I
    Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study
    J Clin Med Res 8: 373-378, 2016
  9. Yuasa S, Sato K, Takai M, Ishikawa M, Umezawa S, Kubota A, Maeda H, Kanamori A, Miyakawa M,Tanaka Y, Terauchi Y, Matsuba I
    Factor Analysis of Changes in Hemoglobin A1c After 12 Months of Sitagliptin Therapy in Patients With Type 2 Diabetes
    J Clin Med Res 8: 461-471, 2016
  10. Iizuka T, Iemitsu K, Takihata M, Takai M, Nakajima S, Minami N, Umezawa S, Kanamori A, Takeda H, Kawata T, Ito S, Kikuchi T, Amemiya H, Kaneshiro M, Mokubo A, Takuma T, Machimura H, Tanaka K, Asakura T, Kubota A, Aoyagi S, Hoshino K, Ishikawa M, Matsuzawa Y, Obana M, Sasai N, Kaneshige H, Minagawa F, Saito T, Shinoda K, Miyakawa M, Tanaka Y, Terauchi Y, Matsuba I
    Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study
    J Clin Med Res 8: 116-125, 2016
  11. Imamura M, Takahashi A, Yamauchi T, Hara K, Yasuda K, Grarup N, Zhao W, Wang X, Huerta-Chagoya A, Hu C, Moon S, Long J, Kwak SH, Rasheed A, Saxena R, Ma RC, Okada Y, Iwata M, Hosoe J, Shojima N, Iwasaki M, Fujita H, Suzuki K, Danesh J, Jørgensen T, Jørgensen ME, Witte DR, Brandslund I, Christensen C, Hansen T, Mercader JM, Flannick J, Moreno-Macías H, Burtt NP, Zhang R, Kim YJ, Zheng W, Singh JR, Tam CH, Hirose H, Maegawa H, Ito C, Kaku K, Watada H, Tanaka Y, Tobe K, Kawamori R, Kubo M, Cho YS, Chan JC, Sanghera D, Frossard P, Park KS, Shu XO, Kim BJ, Florez JC, Tusié-Luna T, Jia W, Tai ES, Pedersen O, Saleheen D, Maeda S, Kadowaki T
    Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes
    Nat Commun 2016, in press
  12. Matsuba R, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A, Kawamori R, Maeda S
    Replication Study in a Japanese Population of Six Susceptibility Loci for Type 2 Diabetes Originally Identified by a Transethnic Meta-Analysis of Genome-Wide Association Studies
    PLOS ONE 11: e0154093, 2016
  13. Tenjin A, Nagai Y, Yuji S, Ishii S, Kato H, Ohta A, Tanaka Y
    Short-term change of carotid intima-media thickness after treatment of hyperglycemia in patients with diabetes: a cross -sectional study
    BMC Res Notes 9: 281, 2016
  14. Matsubara F, Katabami T, Asai S, Ariizumi Y, Maeda I, Takagi M, M McNamara K, Ono K, Maekawa T, Nakamura Y, Tanaka Y, Sasano H
    Immunohistochemical analysis of insulin-like growth factor 1 and its receptor in sporadic schwannoma/peripheral nerve sheath tumour
    J Int Med Res 44: 662-672, 2016

 

2015年

  1. Maeda H, Kubota A, Kanamori A, Tanaka Y, Terauchi Y, Matsuba I, Study Group of Diabetes Committee, Kanagawa Physicians Association
    Effects of sitagliptin on the serum creatinine in Japanese type 2 diabetes
    Diabetes Res Clin Pract 108: e42-45, 2015
  2. Nakamura Y, Nagai Y, Terashima Y, Nishine A, Ishii S, Kato H, Ohta A, Tanaka Y
    Better response to the SGLT2 inhibitor dapagliflozin in young adults with type 2 diabetes
    Expert Opin Pharmacother 16: 2553-2559, 2015
  3. Matsuba R, Sakai K, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A, Kawamori R, Maeda S
    Replication Study in a Japanese Population to Evaluate the Association between 10 SNP Loci, Identified in European Genome-Wide Association Studies, and Type 2 Diabetes
    PLOS ONE 10: e0126363, 2015
  4. Kato H, Nagai Y, Ohta A, Tenjin A, Nakamura Y, Tsukiyama H, Sasaki Y, Fukuda H, Ohshige T, Terashima Y, Sada Y, Kondo A, Sasaoka T, Tanaka Y
    Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes
    Diabetes Res Clin Pract 109: 199-205, 2015
  5. Umakoshi H, Tanase-Nakao K, Wada N, Ichijo T, Sone M, Inagaki N, Katabami T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Tsuiki M, Shimatsu A, Naruse M
    Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism.
    Clin Endocrinol (Oxf) 83: 462-467, 2015

 

2014年

  1. Kawata T, Kanamori A, Kubota A, Maeda H, Amamiya H, Takai M, Kaneshige H, Minagawa F, Iemitsu K, Kaneshiro M, Ishikawa M, Takeda H, Takuma T, Mokubo A, Machimura H, Obana M, Miyakawa M, Naka Y, Terauchi Y, Toyoda M, Suzuki D, Tanaka Y, Matsuba I
    Clinical effects of liraglutide on diabetes control in Japanese type 2 diabetes mellitus patients
    Diabetol Int 5: 98-104, 2014
  2. Asai S, Ohta A, Kato H, Sada Y, Nagai Y, Kondo A, Sasaoka T, Tanaka Y
    Effect of sitagliptin on glycemic control and beta cell function in Japanese patients given basal-supported oral therapy for type 2 diabetes
    Endocr J 61: 1213-1220, 2014
  3. Tanase-Nakao K, Naruse M, Nanba K, Tsuiki M, Tagami T, Usui T, Okuno H, Shimatsu A, Hashimoto S, Katabami T, Ogo A, Okumura A, Umakoshi H, Suzuki T
    Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism
    Clin Endocrinol (Oxf) 81: 665-670, 2014
  4. Kawashima ST, Usui T, Tenjin A, Asai S, Tanaka Y, Hoshikawa M, Shimatsu A, Katabami T
    A In Silico Analysis Identification of a Novel Germ-Line VHL Mutation in a Patient of Malignant Pheochromocytoma
    Endocr Pract 20: e96-e101, 2014
  5. Katabami T, Murakami M, Kobayashi S, Matsui T, Ujihara M, Takagi S, Higa M, Ichijo T, Ohta A, Tanaka Y
    Efficacy of low-dose rosuvastatin in patients with type 2 diabetes and hypo high-density lipoprotein cholesterolemia
    J Int Med Res 42: 457-467, 2014
  6. Pheochromocytoma Study Group in Japan, Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M
    Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma
    Endocr Relat Cancer 21: 405-414, 2014
  7. Takai M, Ishikawa M, Maeda H, Kanamori A, Kubota A, Amemiya H, Iizuka T, Iemitsu K, Iwasaki T,
    Uehara G, Umezawa S, Obana M, Kaneshige H, Kaneshiro M, Kawata T, Sasai N, Saito T, Takuma T, Takeda H, Tanaka K, Tsurui N, Nakajima S, Hoshino K, Honda S, Machimura H, Matoba K, MInagawa F, Minami N, Miyairi Y, Mokubo A, Motomiya T, Waseda M, Miyakawa M, Naka Y, Terauchi Y, Tanaka Y, Matsuba I
    Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: The ASSIST-K study
    Diabetes Res Clin Pract 103: e30-3, 2014
  8. Ohta A , Kato H, Murayama K, Hashimoto E, Murakami M, Nishine A, Ohshige T, Sada Y, Asai S, Kawata T, Nagai Y, Katabami T, Tanaka Y
    Effect of insulin glargine on endogenous insulin secretion and beta-cell function in Japanese type 2 diabetic patients using oral antidiabetic drugs
    Endocr J 61: 13-18, 2014
  9. Nagai Y, Hashimoto E, Oikawa R, Asai S, Terashima Y, Nakamura Y, Sasaki Y, Tsukiyama H, Fukuda H, Ohshige T, Kato H, Ohta A, Tanaka Y
    Differing effects of liraglutide on gastric emptying in Japanese patients with type 2 diabetes
    Diabetes Obes Metab 16: 573-576, 2014
  10. Kawata T, Kanamori A, Kubota A, Maeda H, Amemiya H, Takai M, Kaneshige H, Minagawa F, Iemitsu K, Kaneshiro M, Ishikawa M, Takeda H, Takuma T, Mokubo A, Machimura H, Obana M, Miyakawa M, Naka Y, Suzuki D, Terauchi Y, Toyoda M, Tanaka Y, Matsuba I
    Is a switch from insulin therapy to liraglutide possible in Japanese type 2 diabetes mellitus patients?
    J Clin Med Res 6: 138-144, 2014
  11. Miyake Y, Tanaka K, Nishikawa T, Naruse M, Takayanagi R, Sasano H, Takeda Y, Shibata H, Sone M, Sato F, Yamada M, Ueshiba H, Katabami T, Iwasaki Y, Tanaka H, Tanahashi Y, Suzuki S, Hasegawa T, Katsumata N, Tajima T, Yanase T
    Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study
    Endocr J 61: 35-40, 2014

 

2013年

  1. Ohta A, Arai K, Nishine A, Sada Y, Kato H, Fukuda H, Asai S, Nagai Y, Katabami T, Tanaka Y
    Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic receiving preprandial insulin aspart or postprandial insulin glulisine
    Endocr J 60: 173-177, 2013
  2. Nanba K, Tsuiki M, Sawai K, Mukai K, Nishimoto K, Usui T, Tagami T, Okuno H, Yamamoto T, Shimatsu A, Katabami T, Okumura A, Kawa G, Tanabe A, Naruse M
    Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry
    J Clin Endocrinol Metab 98: 1567-1574, 2013
  3. Ohta A, Kato H, Nakamura Y, Tenjin A, Sakai K, Tukiyama H, Terashima Y, Nagai Y, Tanaka Y
    Cold-loaded pain sensation test and current perception threshold for evaluation of diabetic neuropathy
    Diabetol Int 4: 34-39, 2013
  4. Nagai Y, Ohshige T, Arai K, Kobayashi H, Sada Y, Omori S, Furukawa K, Kato H, Kawata T, Ohta A,Tanaka Y
    Comparison between shorter straight and thinner microtapered insulin Injection needles
    Diabetes Technol Ther 15: 550-555, 2013
  5. Fukuda H, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A, Kawamori R, Maeda S
    Replication study for the association of a single-nucleotide polymorphism, rs3746876,within KCNJ15, with susceptibility to type 2 diabetes in a Japanese population
    J Human Genet 58: 490-493, 2013
  6. Ohta A, Ohshige T, Sakai K, Nakamura Y, Tenjin A, Tsukiyama S, Terashima Y, Matsubara F, Kawata T, Nagai Y, Tanaka Y
    Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes
    Expert Opin Pharmacother 14: 2315-2322, 2013
  7. Erion MD, Popov V, Hsiao JJ, Vatner D, Mitchell K, Yonemitsu S, Nagai Y, Kahn M, Gillum PM, Dong J, Murray FS, Manchem PV, Bhanot S, Cline WG, Shulman IG, Samuel T
    The role of the carbohydrate response element-binding protein in male fructose-fed rats
    Endocrinology 154: 36-44, 2013
  8. Imamura M, Iwata M, Maegawa H, Watada H, Hirose H, Tanaka Y, Tobe K, Kaku K, Kashiwagi A,Kadowaki T, Kawamori R, Maeda S
    Replication study for association of rs391300 in SRR and rs17584499 in PTPRD with susceptibility to type 2 diabetes in a Japanese population
    J Diabetes Invest 4: 168-173, 2013
  9. Kawata T, Ohta A, Nemoto T, Nishisako H, Yamasaki Y, Hirose M, Kunishima H, Matsuda T, Tanaka Y
    A Case of Slowly Progressive Insulin-dependent Diabetes Mellitus (SPIDDM) with Low Anti-GAD Antibody Titer Detected during Treatment of Organizing Pneumonia
    General Med 14: 1-5, 2013
  10. Maeda H, Kubota A, Kanamori A, Tanaka Y, Terauchi Y, Matsuba I, ASSET-K Study Group
    Long-term efficacy and safety of sitagliptin in the treatment of Japanese Type 2 diabetes (ASSET-K1) to a target of HbA1c 7
    J Endocrinol Invest 36: 568-573, 2013

 

2012年

  1. Kubota A, Maeda H, Kanamori A, Matoba K, Jin Y, Minagawa F, Obana M, lemitsu K, Ito S, Amemiya H, Kaneshiro M, Takai Masahiko, Kanesige H, Hoshino K, Ishikawa M, Minami N, Takuma T, Sasai N,
    Aoyagi S, Kawata T, Mokubo A, Takeda H, Honda S, Machimura H, Motomiya T, Waseda M, Naka Y,Tanaka Y, Terauchi Y, Matsuba I
    Pleiotropic Effects of Sitagliptin in the Treatment of Type 2 Diabetes Mellitus Patients
    J Clin Med Res 4: 309-313, 2012
  2. Maeda H, Kubota A, Tanaka Y, Terauchi Y, Matsuba I, ASSET-K Study Group
    The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes
    Diabetes Res Clin Pract 95: 20-22, 2012
  3. Kato H, Ohta A, Kobayashi S, Ishii S, Sada Y, Kobayashi H, Omori S, Kondo A, Katabami T, Fuse J,Fukuda H, Nagai Y, Tanaka Y
    Effect of the α-glucosidase inhibitor miglitol on the glucose profile in Japanese type 2 diabetic patients receiving multiple daily insulin injections
    Endocr J 59: 345-352, 2012
  4. Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D, Yamada M, Uruno T, Horiuchi K, Miyauchi A, Imamura M; MEN Consortium of Japan, Fukushima T, Hanazaki K, Hirakawa S, Igarashi T, Iwatani T, Kammori M, Katabami T, Katai M, Kikumori T, Kiribayashi K, Koizumi S, Midorikawa S, Miyabe R, Munekage T, Ozawa A, Shimizu K, Sugitani I, Takeyama H, Yamazaki M
    Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database
    Clin Endocrinology 76: 533-539, 2012
  5. Miyauchi K, Yamazaki T, Watada H, Tanaka Y, Kawamori R, Imai Y, Ikeda S, Kitagawa A, Ono Y,Murayama F, Choi BJ, Suwa S, Hayashi D, Kishimoto J, Daida H; for the ADVANCED-J investigators
    Management of home blood pressure by amlodipine combined with angiotensin II receptor blocker in type 2 diabetes
    Circulation J 76: 2159-2166, 2012
  6. Imamura M, Maeda S, Yamauchi T, Hara K, Yasuda K, Morizono T, Takahashi A, Horikoshi M, Nakamura M, Fujita H, Tsunoda T, Kubo M, Watada H, Maegawa H, Okada IM, Iwabu M, Shojima N, Ohshige T, Omori S, Iwata M, Hirose H, Kaku K, Ito C, Tanaka Y, Tobe K, Kashiwagi A, Kawamori R, Kasuga M, Kamatani N; Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium, Nakamura Y, Kadowaki T
    A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations
    Human Molecular Genet 121: 3042-3049, 2012
  7. Kondo A, Ohta A, Kato H, Matsubara F, Fukuda H, Kobayashi H, Kawata T, Tanaka Y
    Effect of combination therapy with losartan and low-dose hydrochlorothiazide for albuminuria on the patients with type 2 diabetes mellitus
    Japanese J Clin Physiol 42: 89-95, 2012
  8. Fukuda H, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A, Kawamori R, Maeda S
    A Single nucleotide polymorphism within DUSP9 Is associated with susceptibility to type 2 diabetes in a Japanese population
    PLoS One 7: e46263, 2012
  9. Kawata T, Kanamori A, Kubota A, Maeda H, Matoba K, Ito S, Amamiya H, Takai M, Kaneshige H, Minami N, Minagawa F, Iemitsu K, Ishikawa M, Hoshino K, Miyakawa M, Naka Y, Toyoda M, Terauchi Y, Suzuki D, Tanaka Y, Matsuba I
    Efficacy and safety of liraglutide in patients with type2 diabetes:the SEDIK study
    J Diabetes Invest 3: 203, 2012
  10. Sato T, Katabami T, Furukawa K, Narimatsu H, Hashimoto T, Nakajima Y, Ohta A, Sasaoka T, Tanaka Y
    Intracellular lipid content of liver and skeletal muscle in patients with adult growth hormone deficiency without diabetes mellitus
    Obesity Res Clin Pract 6: e321-e329, 2012

 

2011年

  1. Kamijo IA, Sugaya T, Yasuda T, Kawata T, Ohta A, Tatsunami S, Kaise R, Ishimitsu T, Tanaka Y, Kimura K
    Clinical significance of urinary liver-type fatty acid- binding protein in diabetic nephropathy of type 2 diabetic patients
    Diabetes Care 34: 691-696, 2011
  2. Sada Y, Katabami T, Asai S, Sato T, Furukawa K, Ishii S, Kato H, Kobayashi H, Kondo A, Ohta A, Nakajima Y, Tanaka Y
    Intrahepatic lipid content is linked to insulin resistance in obese subjects
    Obesity Res Clin Pract 5: e129-e136, 2011
  3. Ohshige T, Iwata M, Omori S, Tanaka Y, Hirose H, Kaku K, Maegawa H, Watada H, Kashiwagi A,Kawamori R, Tobe K, Kadowaki T, Nakamura Y, Maeda S
    Association of new loci Identified in European genome-wide association studies with susceptibility to type 2 diabetes in the JapanesePLoS One 6: e26911, 2011
  4. Imamura M, Iwata M, Maegawa H, Watada H, Hirose H, Tanaka Y, Tobe K, Kaku K, Kashiwagi A,Kawamori R, Nakamura Y, Maeda S
    Genetic variants at CDC123/CAMK1D and SPRY2 are associated with susceptibility to type 2 diabetes in the Japanese population Diabetologia 54: 3071-3077, 2011
  5. Ohta A, Suwa T, Sada Y, Kato H, Koganei R, Asai S, Katabami T, Tanaka Y
    Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving biphasic insulin aspart 30 or biphasic human insulin 30 
    J Diabetes Invest 2: 406-411, 2011

 

2010年

  1. Ohshige T, Tanaka Y, Araki S, Babazono T, Toyoda M, Umezono T, Watada H, Suzuki D, Iwamoto Y, Kawamori R, Nakamura Y, Maeda S
    A single nucleotide polymorphism in KCNQ1 Is associated with susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes
    Diabetes Care 33: 842-846, 2010
  2. Suwa T, Ohta A, Matsui T, Koganei R, Kato H, Kawata T, Sada Y, Ishii S, Kondo A, Murakami K, Katabami T, Tanaka Y
    Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM)
    Endocr J 57: 135-140, 2010
  3. Katabami T, Kato H, Asahina T, Hinohara S, Shin T, Kawata T, Ohta A, Iwamoto T, Tanaka Y
    Serum free testosterone and metabolic syndrome in Japanese men
    Endocr J 57: 533-539, 2010
  4. Furukawa K, Katabami T, Nakajima Y, Sato T, Kato H, Koganai R, Asai S, Matsui T, Sada Y, Kawata T, Kondo A, Ohta A, Tanaka Y
    Evaluation of whole-abdominal fat volume by 700-slice CT scanning and comparison with the umbilical fat area anthropometric indices
    Obesity Res Clin Pract 4: e111-e117, 2010
  5. Yamauchi T, Hara K, Maeda S, Yasuda K, Takahashi A, Horikoshi,M Nakamura M, Fujita H, Grarup N, Cauchi S, Daniel PKN, Ronald CWM, Tsunoda T, Kudo M, Watada H, Maegawa H, Okada IM, Iwabu M, Shojima N, Shin DH, Andersen G, Witte RD, Jorgensen T, Lauritzen T, Sandbaek A, Hansen T, Ohshige T, Omori S, Saito I, Kaku K, Hirose H, So WY, Beury D, Chan CNJ, Park SK, Tail SE, Ito C, Tanaka Y, Kashiwagi A, Kawamori R, Kasuga M, Froguel P, Pedersen O, Kamatani N, Nakamura Y, Kadowaki T
    A genome wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B
    Nature Genet 42: 864-868, 2010

 

2009年

  1. Ohmura C, Watada H, Azuma K, Shimizu T, Kanazawa A, Ikeda F, Yoshihara T, Fujitani Y, Hirose T,Tanaka Y, Kawamori R
    Aldose reductase Inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetesEndocr J 56: 149-156, 2009
  2. Asai S, Katabami T, Obi N, Matsui T, Kato H, Obi R, Ogawa Y, Kawata T, Takama H, Ohta A, Tanaka Y
    No ghrelin response to oral glucose in diabetes mellitus with gastroparesis
    Endocr J 56: 79-87, 2009
  3. Obi N, Katabami T, Obi R, Odanaka M, Sasano K, Tanaka Y
    Primary malignant hepatic glucagonoma : an autopsy case
    Endocr J 56: 715-719, 2009
  4. Tanaka Y, Daida H, Imai Y, Miyauchi K, Sato Y, Hiwatari M, Kitagawa A, Kishimoto J, Yamazaki T,Kawamori R
    Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes ADVANCED-J study 1Hypertension Res 32: 770-774, 2009
  5. Omori S, Tanaka Y, Horikoshi M, Takahashi A, Hara K, Hirose H, Kashiwagi A, Kaku K, Kawamori R, Kadowaki T, Nakamura Y, Maeda S
    Replication study for the association of new meta-analysis-derived risk loci with susceptibility to type 2 diabetes in 6,244 Japanese individuals
    Diabetologia 52: 1554-1560, 2009

 

2008年

  1. Tamura Y, Watada H, Igarashi Y, Nomiyama T, Onishi T, Takahashi K, Doi S, Katamoto S, Hirose T, Tanaka Y, Kawamori R
    Short-term effects of dietary fat on intramyocellular lipid in sprinters and endurance runners.
    Metabolism 57: 373-379, 2008
  2. Tamura Y, Watada H, Sato F, Kumashiro N, Sakurai Y, Hirose T, Tanaka Y, Kawamori R
    Effects of metformin on peripheral Insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects
    Diabetes Obesity Metab 10: 733-738, 2008
  3. Obi N, Katabami T, Asai S, Saito N, Tanaka Y
    Fulminant Type 1 diabetes complicated by leukemoid reaction
    Intern Med 47: 847-851, 2008
  4. Amano T, Imano T, Takemae K, Iwamoto T, Yamanaka K, Baba K, Nakanome M, Sugimori H, Tanaka Y, Yoshida K, Katabami T, Tanaka M
    Profile of serum testosterone levels after application of testosterone ointment (glowmin) and Its clinical efficacy in late-onset hypogonadism patients
    J Sex Med 5: 1727-1736, 2008

 

2007年

  1. Tamura Y, Ogihara T, Uchida T, Ikeda F, Kumashiro N, Nomiyama T, Sato F, Hirose T, Tanaka Y, Mochizuki H, Kawamori R, Watada H
    Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappab in db/db mice
    Diabetologia 50: 131-141, 2007
  2. Sugai M, Ohta A, Ogata Y, Nakanishi M, Ueno S, Kawata T, Saito N, Tanaka Y
    Asymmetric dimethylarginine(ADMA) in the anqueous humor of diabetic patients
    Endocr J 54: 303-309, 2007
  3. Nakaniwa T, Nomiyama T, Takahashi S, Sakai K, Uchino H, Shimizu T, Kanazawa A, Watada H, Hirose T, Kawamori R, Tanaka Y
    Manganese superoxide dismutase polymorphism (V16A) associated with inpaired cardiac autonomic function in Japanese type 2 deiabetid patients.
    Jpn J Clin Physiol 37: 27-34, 2007
  4. Ohta A, Omori S, Obi R, Tanaka Y
    Penile necrosis by calciphylaxis in a diabetic patient with chronic renal failure
    Internal Med 46: 985-990, 2007
  5. Kumashiro N, Yoshihara T, Kanazawa Y, Shimizu T, Watada H, Tanaka Y, Fujitani Y, Kawamori R, Hirose T
    Long-term effect of combination therapy with mitiglinide and once daily Insulin glargine in patients who were succesfully switched from Intensive Insulin therapy in short-term study
    Endocr J 54: 163-166, 2007
  6. Sato F, Tamura Y, Watada H, Kumashiro N, Igarashi Y, Uchino H, Maehara T, Kyogoku S, Sunayama S, Sato H, Hirose T, Tanaka Y, Kawamori R
    Effects of diet-induced moderate weight reduction on intrahepatic and Intramyocellular triglycerides and glucose metabolism in obese subjects
    J Clin Endocrinology Metab 92: 3326-3329, 2007
  7. Ikeda F, Azuma K, Ogihara T, Toyofuku Y, Otsuka A, Mita T, Hirose T, Tanaka Y, Kawamori R, Watada H
    Angiotenshin type 1 receptor blocker reduces monocyte adhesion to endothelial cells in pontaneously hypertensive rats
    Endocr J 54: 605-612, 2007
  8. Omori S, Tanaka Y, Takahashi A, Hirose H, Kashiwagi A, Kaku K, Kawamori R, Nakamura Y, Maeda S
    Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8 and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population
    Diabetes 57: 791-795, 2007
  9. Kanazawa Y, Igarashi Y, Komiya K, Sakurai Y, Shimizu T, Fujitani Y, Tanaka Y, Watada H, Kawamori R, Hirose T
    Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1).
    Endocr J 54: 975-983, 2007
  10. Mita T, Watada H, Shimizu T, Tamura Y, Sato F, Watanabe T, Choi BJ, Hirose T, Tanaka Y, Kawamori R
    Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control
    Arterioscler Thromb Vasc Biol 27: 2456-2462, 2007